There is no way a pharmaceutical company would spe
Post# of 148109
1) companies don't buy access to products like this without figuring their possible return on investment.
2) Too many physicians already know about Leronlimab and would raise a ruckus if it were to disappear somehow.
3) Please worry about something else you can't control like sunspots or politics or earthquakes.